CN104878099A - 山羊atbf1基因单核苷酸多态性的检测方法及其应用 - Google Patents
山羊atbf1基因单核苷酸多态性的检测方法及其应用 Download PDFInfo
- Publication number
- CN104878099A CN104878099A CN201510250256.2A CN201510250256A CN104878099A CN 104878099 A CN104878099 A CN 104878099A CN 201510250256 A CN201510250256 A CN 201510250256A CN 104878099 A CN104878099 A CN 104878099A
- Authority
- CN
- China
- Prior art keywords
- goat
- genotype
- atbf1 gene
- atbf1
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000283707 Capra Species 0.000 title claims abstract description 137
- 101000744900 Homo sapiens Zinc finger homeobox protein 3 Proteins 0.000 title claims abstract description 99
- 238000000034 method Methods 0.000 title claims abstract description 38
- 239000002773 nucleotide Substances 0.000 title claims abstract description 33
- 238000000246 agarose gel electrophoresis Methods 0.000 claims abstract description 24
- 230000012010 growth Effects 0.000 claims abstract description 17
- 108091008146 restriction endonucleases Proteins 0.000 claims abstract description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 31
- 238000009395 breeding Methods 0.000 claims description 28
- 230000001488 breeding effect Effects 0.000 claims description 28
- 239000003795 chemical substances by application Substances 0.000 claims description 26
- 239000003147 molecular marker Substances 0.000 claims description 21
- 239000012634 fragment Substances 0.000 claims description 12
- 235000013336 milk Nutrition 0.000 claims description 12
- 239000008267 milk Substances 0.000 claims description 12
- 210000004080 milk Anatomy 0.000 claims description 12
- 239000003550 marker Substances 0.000 claims description 10
- 238000011144 upstream manufacturing Methods 0.000 claims description 10
- 238000012408 PCR amplification Methods 0.000 claims description 8
- 230000003321 amplification Effects 0.000 claims description 6
- 238000001976 enzyme digestion Methods 0.000 claims description 6
- 210000001981 hip bone Anatomy 0.000 claims description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 6
- 235000013365 dairy product Nutrition 0.000 claims description 5
- 238000004925 denaturation Methods 0.000 claims description 5
- 230000036425 denaturation Effects 0.000 claims description 5
- 238000012257 pre-denaturation Methods 0.000 claims description 5
- 238000004153 renaturation Methods 0.000 claims description 5
- 238000009394 selective breeding Methods 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 abstract description 15
- 238000001962 electrophoresis Methods 0.000 abstract description 12
- 230000002068 genetic effect Effects 0.000 abstract description 11
- 238000011161 development Methods 0.000 abstract description 9
- 108090000623 proteins and genes Proteins 0.000 description 37
- 108020004414 DNA Proteins 0.000 description 32
- 238000001514 detection method Methods 0.000 description 19
- 108700028369 Alleles Proteins 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 16
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 16
- 230000035772 mutation Effects 0.000 description 14
- 102100039966 Zinc finger homeobox protein 3 Human genes 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 230000007614 genetic variation Effects 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 238000005520 cutting process Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 102100031780 Endonuclease Human genes 0.000 description 6
- 108010042407 Endonucleases Proteins 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241001494479 Pecora Species 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 238000010369 molecular cloning Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 238000010219 correlation analysis Methods 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 4
- 229960005542 ethidium bromide Drugs 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 108010051696 Growth Hormone Proteins 0.000 description 3
- 102100024819 Prolactin Human genes 0.000 description 3
- 108010057464 Prolactin Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 102100038803 Somatotropin Human genes 0.000 description 3
- 101150055123 afp gene Proteins 0.000 description 3
- 238000007844 allele-specific PCR Methods 0.000 description 3
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000000122 growth hormone Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 229940097325 prolactin Drugs 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- QSLFDILMORXPKP-UHFFFAOYSA-N (3-methylimidazol-3-ium-1-yl)-methylsulfanylphosphinate Chemical compound CSP([O-])(=O)N1C=C[N+](C)=C1 QSLFDILMORXPKP-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 239000006126 MAS system Substances 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 101710129981 Pituitary-specific positive transcription factor 1 Proteins 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000003975 animal breeding Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- ZEDPQIJYJCPIRM-UHFFFAOYSA-N dimethyl benzonitrile Natural products CC1=CC=CC(C#N)=C1C ZEDPQIJYJCPIRM-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000001817 pituitary effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 102000055046 tissue-factor-pathway inhibitor 2 Human genes 0.000 description 2
- 108010016054 tissue-factor-pathway inhibitor 2 Proteins 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 1
- IKHKJYWPWWBSFZ-UHFFFAOYSA-N 4-[[4-(diethylamino)phenyl]-(4-diethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]benzene-1,3-disulfonate;hydron Chemical compound C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=CC=1)S([O-])(=O)=O)S(O)(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 IKHKJYWPWWBSFZ-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 102100030837 E3 SUMO-protein ligase PIAS3 Human genes 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010020382 Hepatocyte Nuclear Factor 1-alpha Proteins 0.000 description 1
- 102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 description 1
- 101000583444 Homo sapiens E3 SUMO-protein ligase PIAS3 Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102100037914 Pituitary-specific positive transcription factor 1 Human genes 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 102000004495 STAT3 Transcription Factor Human genes 0.000 description 1
- 108010017324 STAT3 Transcription Factor Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000008051 TBE buffer Substances 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 210000002593 Y chromosome Anatomy 0.000 description 1
- 101710180292 Zinc finger homeobox protein 3 Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000012098 association analyses Methods 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000008143 early embryonic development Effects 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 230000023247 mammary gland development Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- RIGXBXPAOGDDIG-UHFFFAOYSA-N n-[(3-chloro-2-hydroxy-5-nitrophenyl)carbamothioyl]benzamide Chemical compound OC1=C(Cl)C=C([N+]([O-])=O)C=C1NC(=S)NC(=O)C1=CC=CC=C1 RIGXBXPAOGDDIG-UHFFFAOYSA-N 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510250256.2A CN104878099B (zh) | 2015-05-15 | 2015-05-15 | 山羊atbf1基因单核苷酸多态性的检测方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510250256.2A CN104878099B (zh) | 2015-05-15 | 2015-05-15 | 山羊atbf1基因单核苷酸多态性的检测方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104878099A true CN104878099A (zh) | 2015-09-02 |
CN104878099B CN104878099B (zh) | 2018-02-16 |
Family
ID=53945772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510250256.2A Expired - Fee Related CN104878099B (zh) | 2015-05-15 | 2015-05-15 | 山羊atbf1基因单核苷酸多态性的检测方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104878099B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106854676A (zh) * | 2016-12-27 | 2017-06-16 | 江苏大学 | 一种基于酶切检测snp的方法 |
CN108192985A (zh) * | 2018-03-07 | 2018-06-22 | 西北农林科技大学 | 一种山羊ctnnb1基因插入/缺失的检测方法及其应用 |
CN108441566A (zh) * | 2018-04-04 | 2018-08-24 | 西北农林科技大学 | 一种山羊atbf1基因插入/缺失多态性的检测方法及其应用 |
CN110172516A (zh) * | 2019-03-21 | 2019-08-27 | 西北农林科技大学 | 检测黄牛lncFAM200B基因5’侧翼区单核苷酸多态性的方法及其应用 |
CN110607373A (zh) * | 2019-09-17 | 2019-12-24 | 西北农林科技大学 | 一种山羊dnah1基因插入/缺失多态性的检测方法及其应用 |
CN111118178A (zh) * | 2020-02-18 | 2020-05-08 | 天津奥群牧业有限公司 | 绵羊ghr基因插入/缺失多态性的检测引物对、试剂盒、方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130324427A1 (en) * | 2006-04-27 | 2013-12-05 | Biosystemix Ltd. | Assessment and reduction of risk of graft-versus-host disease |
CN103866032A (zh) * | 2014-03-28 | 2014-06-18 | 西北农林科技大学 | 一种检测山羊stat3基因单核苷酸多态性的方法及其应用 |
-
2015
- 2015-05-15 CN CN201510250256.2A patent/CN104878099B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130324427A1 (en) * | 2006-04-27 | 2013-12-05 | Biosystemix Ltd. | Assessment and reduction of risk of graft-versus-host disease |
CN103866032A (zh) * | 2014-03-28 | 2014-06-18 | 西北农林科技大学 | 一种检测山羊stat3基因单核苷酸多态性的方法及其应用 |
Non-Patent Citations (1)
Title |
---|
钟林等: "ATBF1 研究综述", 《现代生物医学进展》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106854676A (zh) * | 2016-12-27 | 2017-06-16 | 江苏大学 | 一种基于酶切检测snp的方法 |
CN108192985A (zh) * | 2018-03-07 | 2018-06-22 | 西北农林科技大学 | 一种山羊ctnnb1基因插入/缺失的检测方法及其应用 |
CN108192985B (zh) * | 2018-03-07 | 2020-02-21 | 西北农林科技大学 | 一种山羊ctnnb1基因插入/缺失的检测方法及其应用 |
CN108441566A (zh) * | 2018-04-04 | 2018-08-24 | 西北农林科技大学 | 一种山羊atbf1基因插入/缺失多态性的检测方法及其应用 |
CN108441566B (zh) * | 2018-04-04 | 2021-06-29 | 西北农林科技大学 | 一种山羊atbf1基因插入/缺失多态性的检测方法及其应用 |
CN110172516A (zh) * | 2019-03-21 | 2019-08-27 | 西北农林科技大学 | 检测黄牛lncFAM200B基因5’侧翼区单核苷酸多态性的方法及其应用 |
CN110172516B (zh) * | 2019-03-21 | 2022-05-17 | 西北农林科技大学 | 检测黄牛lncFAM200B基因5’侧翼区单核苷酸多态性的方法及其应用 |
CN110607373A (zh) * | 2019-09-17 | 2019-12-24 | 西北农林科技大学 | 一种山羊dnah1基因插入/缺失多态性的检测方法及其应用 |
CN111118178A (zh) * | 2020-02-18 | 2020-05-08 | 天津奥群牧业有限公司 | 绵羊ghr基因插入/缺失多态性的检测引物对、试剂盒、方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104878099B (zh) | 2018-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104878099B (zh) | 山羊atbf1基因单核苷酸多态性的检测方法及其应用 | |
CN108410994B (zh) | 一种影响湖羊产羔性状的snp标记及其应用 | |
CN109880890B (zh) | 一种山羊hiat1基因插入/缺失多态性的检测方法及其应用 | |
CN109929935B (zh) | 一种基于rs80995809位点基因分型鉴定猪背膘厚的方法及其应用 | |
CN110273010B (zh) | 一种mc1r基因单倍型的鉴定与应用方法 | |
CN108103208B (zh) | 一种影响湖羊产羔性状的snp标记及其应用 | |
CN110468218B (zh) | 一种山羊igf2bp1基因插入/缺失标记的检测方法 | |
US11542562B2 (en) | Single nucleotide polymorphism marker related to Chinese horse short stature trait and use thereof | |
CN109825598B (zh) | 一种与澳洲白绵羊毛发粗细极显著相关的snp标记、分子标记及应用 | |
CN109112217B (zh) | 一种与猪体长和乳头数显著关联的遗传标记及应用 | |
CN108251539A (zh) | 一种与鸡屠体性状相关的snp标记及其应用、检测引物、检测试剂盒 | |
CN106636429B (zh) | 黄牛adncr基因单核苷酸多态性的四引物扩增受阻突变体系pcr检测方法及其应用 | |
CN108342496B (zh) | Hbegf基因片段作为猪繁殖性状相关的遗传标记 | |
CN109280709B (zh) | 一种与猪生长及繁殖性状相关的分子标记及应用 | |
CN101818195B (zh) | 猪miR-27a前体侧翼序列SNP作为猪产仔数性状的遗传标记及应用 | |
CN110564867B (zh) | 一种秦川牛cfl1基因的snp分子标记及其检测方法 | |
CN106755371B (zh) | 利用pcr-rflp检测绵羊pcnp基因单核苷酸多态性的方法及其应用 | |
CN108441566B (zh) | 一种山羊atbf1基因插入/缺失多态性的检测方法及其应用 | |
CN114150068B (zh) | 一种与猪背膘厚相关的snp标记及其应用 | |
CN109207611A (zh) | 一种与绵羊发情性状相关的snp分子标记及其检测试剂盒和应用 | |
CN108165635B (zh) | Kiaa1462基因启动子区变异位点及其在提高鹅产蛋性能上的应用 | |
CN107779517A (zh) | 一种影响杜洛克种猪瘦肉率性状的分子标记及其应用 | |
CN114561475B (zh) | 一种利用分子标记对鸡进行体重选育的方法及其应用及试剂盒 | |
CN114250307B (zh) | 一种评价猪达100kg体重日龄的分子标记及其应用 | |
CN114250305B (zh) | 一种基于glrx3基因检测猪产活仔数和仔猪出生窝重的方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wei Zhenyu Inventor after: Zhang Xiaoyan Inventor after: Chen Hong Inventor after: Lei Chuchao Inventor after: Xu Tieshan Inventor after: Tao Mingliang Inventor after: Lan Xianyong Inventor before: Lan Xianyong Inventor before: Zhang Xiaoyan Inventor before: Chen Hong Inventor before: Lei Chuchao Inventor before: Xu Tieshan Inventor before: Tao Mingliang |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180216 Termination date: 20190515 |